| |
FOR IMMEDIATE RELEASE
Contact:
Steve McPhail
919-405-2248
smcphail@expressionanalysis.com
Entrepreneur and PricewaterhouseCoopers Release 11th Annual Hot 100 Listing of Fastest-Growing New Companies in the U.S.
Irvine, California (May 24, 2005) –Entrepreneur magazine has released its annual Hot 100 listing of the fastest-growing new companies in the United States.
For the second time, Expression Analysis, Inc. -the leading provider of genomic microarray testing services-has been named as one of the top 100 fastest-growing new entrepreneurial companies, having grown its revenue by 80% in 2004.
Expression Analysis, founded in September 2001, provides high quality genomic services and data analysis solutions to over 250 customers in the pharmaceutical, biotech, and academic industries. Having been the first to achieve several regulatory compliance milestones, the company offers services applicable throughout the drug development process. The company is now generating data for over 40 pharmaceutical clinical trials and has collaborated with the FDA to assist the Agency in understanding how genomic data might be used in regulatory submissions.
“Expression Analysis is uniquely positioned to provide microarray-based genomic testing services for pharmaceutical clinical trials. Genomic data has the potential to move us closer to personalized medicine, where by understanding a patient’s genetic profile, a physician can pick the right drug at the right dose thus maximizing therapeutic efficacy and minimizing unwanted side effects,” said Steve McPhail, Expression Analysis President and CEO.
Steve Casey, COO and Founder, attributes the company’s success to its employees and their execution in delivering the highest quality genomic processing services to its clients. “We unquestionably hang our hats and our reputation on our quality and customer service,” said Casey. “We work extremely hard to support our clients and know they rely on us to advance their research efforts with our service, quality and innovation. Our greatest reward is seeing their research develop”.
About Expression Analysis
Expression Analysis, Inc., (EA) (www.expressionanalysis.com) is a full-service microarray genomics testing and analysis organization dedicated to providing clients with the highest quality genomic processing and data analysis services using Affymetrix GeneChip® brand technology. In 2004, EA became the first microarray services facility, worldwide, to provide GLP-compliant services. EA is a U.S.-based authorized service provider for Affymetrix (www.affymetrix.com), a California-based company that develops and commercializes systems to help researchers explore the relationship between genes and human health.
|
|
